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Abstract 
Objective: To identify health-related quality of life (HRQOL) trajectories during 18 months of 
predialysis care and associated patient characteristics and illness perceptions.  Methods: 396 
incident predialysis patients participating in the prospective PREPARE-2 study completed every 
six months the SF-36 (i.e. mental and physical HRQOL) and Revised Illness Perception Ques-
tionnaire.  HRQOL trajectories were examined using latent class growth models, and associated 
baseline factors were identified using logistic regression.  Analyses for illness perceptions were 
adjusted for demographic and clinical characteristics.  Results: Three physical HRQOL trajecto-
ries (low-stable [34.1% of the sample], medium-declining [32.5%], and high-increasing [33.4%]) 
and two mental HRQOL trajectories (low-stable [38.7%] and high-stable [61.3%]) were identi-
fied.  Increased odds for a low-stable physical HRQOL trajectory were detected in older patients 
(OR=1.04), patients with cardiovascular disease (OR=2.1) and patients who believed to a lesser 
extent they can personally control their disease (ORadj=0.88).  Increased odds for both a low-
stable physical and mental HRQOL trajectory were detected in patients who believed to a higher 
extent that their disease is cyclical, has negative consequences, causes negative feelings, and in 
patients who believed to a lesser extent they understand their disease (ORadj ranged between 0.84 
and 1.36).  Additionally, patients who attributed more symptoms to their disease had increased 
odds for a medium-declining (ORadj=1.21) and low-stable physical HRQOL trajectory (ORadj= 
1.50).  Conclusions: Older age and cardiovascular disease are markers for unfavorable physical 
HRQOL trajectories, and stronger negative illness perceptions are markers for unfavorable phy-
sical and mental HRQOL trajectories.  Targeting negative illness perceptions could possibly 
optimize HRQOL during predialysis care.   




Keywords: Chronic kidney disease (CKD); Health-related quality of life (HRQOL); Trajectories; 
Illness perceptions; Latent class growth model; Predialysis care. 
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Health-Related Quality of Life Trajectories during Predialysis Care and Associated Illness 
Perceptions 
 
Individuals with chronic kidney disease (CKD) suffer from a gradual and irreversible loss 
of kidney function.  For the majority of patients, this deterioration in kidney function is accompa-
nied by an increase in symptoms, lifestyle restrictions, and dependency on complex treatment re-
gimens.  Consequently, this disease imposes a heavy burden on people’s lives, and has a disrup-
tive impact on their health, ability to work, emotional well-being, and social participation (Tong 
et al., 2009). 
An important indication of how a disease affects the physical, psychological, and social as-
pects of patients’ lives, is their rating of health-related quality of life (HRQOL).  In patients with 
end-stage renal disease (ESRD), HRQOL is severely impaired (Lim, Yu, Kang, Foo, & Griva, 
2016).  However, a compromised HRQOL is also evidenced in patients with moderately reduced 
kidney function and in patients receiving predialysis care (i.e. CKD stages 3-5) (Chin et al., 2008; 
de Goeij et al., 2014; Kusek et al., 2002), and lower levels of HRQOL in these earlier stages of 
CKD have been associated with accelerated progression towards ESRD and mortality (de Goeij 
et al., 2014; Tsai et al., 2010).  Therefore, predialysis care not only aims to maximize disease 
control, but optimizing HRQOL is considered an important treatment goal as well (Sijpkens, 
Berkhout-Byrne, & Rabelink, 2008). 
Unfortunately, literature regarding HRQOL in patients receiving predialysis care is domi-
nated by cross-sectional studies, and the longitudinal studies that have been conducted found con-
tradictory results regarding the course of HRQOL; some studies found that mean levels of both 
physical and mental HRQOL decreased over time (de Goeij et al., 2014; Fukuhara et al., 2007; 
Mujais et al., 2009), other studies only found changes in one specific physical or mental HRQOL 
domain (e.g. increased mental health [Da Silva-Gane et al., 2012], increased social functioning 
[Hansen, Chin, Blalock, & Joy, 2009] and decreased physical function (Revicki et al., 1995)]), 
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and there are also studies that found no change in physical or mental HRQOL over time [Di 
Micco et al., 2009; Gorodetskaya et al., 2005]).  These contradictory results might be due to 
differences in study design or patient characteristics, but it is also possible that examining mean 
levels of HRQOL over time masks individual variation in the course of HRQOL.  Individuals 
may differ to a large extent in how their HRQOL develops over time, and the identification of 
distinct HRQOL trajectories and associated factors could enable personalized treatment ap-
proaches in predialysis care.  However, to the best of our knowledge, no studies have been con-
ducted that identify HRQOL trajectories during predialysis care using optimal statistical methods 
such as latent class growth modelling (Nagin & Odgers, 2010) and identified factors associated 
with these trajectories.  
Evidently, previous studies do not provide evidence about factors associated with distinct 
HRQOL trajectories during predialysis care, but they do point out potentially important factors, 
including age, gender, kidney function, comorbidities, body mass index (BMI), and levels of 
albumin and hemoglobin (Chin et al., 2008; Gorodetskaya et al., 2005; Hansen et al., 2009; 
Kusek et al., 2002; Mujais et al., 2009; Porter et al., 2012).  Additionally, literature suggests that 
patients’ cognitive appraisal of illness might play a key role in understanding HRQOL: according 
to the Common Sense Model of self-regulation (Leventhal, Meyer, & Nerenz, 1980; Leven-
thal, Nerenz, & Steele, 1984), illness perceptions affect how patients respond to and cope 
with a health threat, and subsequently contribute to health outcomes.  Indeed, studies in 
patients with CKD show that stronger negative perceptions of illness are associated with 
various health outcomes, including depressive symptoms (Chilcot et al., 2013), faster disease 
progression (Meuleman et al., 2015), mortality (Chilcot, Wellsted, & Farrington, 2011; van 
Dijk et al., 2009) and impaired HRQOL (Covic, Seica, Gusbeth-Tatomir, Gavrilovici, & 
Goldsmith, 2004; Covic, Seica, Mardare, & Gusbeth-Tatomis, 2006; Fowler & Baas, 2006; 
Griva, Jayasena, Davenport, Harrison, & Newman, 2009; Timmers et al., 2008).  However, 
until now, the relationship between illness perceptions and HRQOL has only been investi-
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gated in patients with ESRD and information about the longitudinal association is scarce.  
Examining associations between illness perceptions and HRQOL trajectories during pre-
dialysis care could allow the identification of unhelpful illness perceptions and create 
opportunities to improve HRQOL in earlier stages of CKD.   
Therefore, the aim of this study was to examine whether distinct physical and mental 
HRQOL trajectories during predialysis care could be detected, and to examine if these trajec-
tories are associated with illness perceptions (eight domains: illness identity, timeline acute/ 
chronic, timeline cyclical, negative consequences, personal control, treatment control, illness 
coherence, and emotional response), demographic (age and gender) and clinical (BMI, comorbi-
dities, kidney function, time since CKD diagnosis, and levels of albumin and hemoglobin) cha-
racteristics.  It was hypothesized that distinct HRQOL trajectories would be observed and that 
the factors would differ across the identified trajectories.  Due to lacking or inconsistent evidence, 
no directional a priori hypotheses were formulated. 
 
Method 
Study Design   
The PREdialysis PAtient REcord-2 (PREPARE-2) study is a prospective follow-up study in 
25 specialized nephrology outpatient clinics in the Netherlands.  Between July 2004 and June 
2011, patients were included at the moment of referral to one of the participating clinics, where 
they received regular treatment by a multidisciplinary team (consisting of a nephrologist, a nurse 
practitioner, a dietician, and a social worker) according to the Dutch Federation of Nephrology 
treatment guidelines (Multidisciplinary guidelines predialysis, 2011; based on Kidney Disease 
Outcomes Quality Initiative [K/DOQI, 2002] and Kidney Disease Improving Global Outcomes 
[KDIGO, 2012] guidelines).  Patients were followed until initiation of dialysis, kidney transplan-
tation, a recovered kidney function, transferal to non-participating centers, refusal of further 
participation, death, lost during follow-up, or the end of follow-up (13 May 2015).  Approval by 
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the Medical Ethics Committee or Institutional Review Board of all participating centers was 
obtained.1 
 
Patients   
Incident predialysis patients (i.e. within the previous six months referred to a specialized 
predialysis outpatient clinic) with progressive renal failure and an estimated glomerular filtration 
rate (eGFR) of less than 30 ml/min/1.73m2 (i.e. CKD stages 4–5), were eligible for inclusion, if 
they were at least 18 years of age.  Patients with a kidney transplant dysfunction were also inclu-
ded, if patients received a donor kidney transplant at least one year ago.  Prior to study inclusion, 
written informed consent was obtained from all participants. 
 
Data, Definitions, and Measurements 
Demographic and clinical data were collected during routine visits at the clinics: at the 
start of predialysis care, at every subsequent 6-month interval, and at the end of follow-up.  All 
clinical measurements were collected according to the standard care of each clinic, and laboratory 
measurement were periodically extracted from medical records and electronic hospital informa-
tion systems.  As indicator for kidney function, eGFR was calculated by using the abbreviated 
Modification of Diet in Renal Disease formula (Levey, Greene, Kusek, & Beck, 2000).  Based on 
information from medical records, comorbidities were classified as follows: diabetes mellitus 
(DM; type 1 or type 2), and cardiovascular disease (CVD; myocardial infarction, coronary 
disease, and/or angina pectoris).   
                                                 
1 Participating centers: Academic Medical Center (Amsterdam), Sint Lucas-Andreas Hospital (Amsterdam), VU 
Medical Center (Amsterdam), Gelre Hospitals (Apeldoorn), Amphia Hospital (Breda), Reinier de Graaf (Delft), 
Jeroen Bosch Hospital (Den Bosch), Medical Center Haaglanden (The Hague), Hospital Gelderse Vallei (Ede), 
Catharina Hospital (Eindhoven), Scheper Hospital (Emmen), Dialysis Clinic North (Beilen), Admiraal de Ruyter 
Hospital (Goes), Groene Hart Hospital (Gouda), University Medical Center Groningen (Groningen), Kennemer 
Gasthuis (Haarlem), Medical Center Leeuwarden (Leeuwarden), Leiden University Medical Center (Leiden), 
Rijnland Hospital (Leiderdorp), Laurentius Hospital (Roermond), Franciscus Hospital (Roosendaal), Franciscus 
Gasthuis (Rotterdam), Máxima Medical Center (Veldhoven), Zaans Medical Center (Zaandam), Isala Clinics 
(Zwolle). 
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Patients were also asked to fill out a questionnaire at home, and return the questionnaire as 
soon as possible.  The questionnaire included the 36-item Short Form Health Survey Question-
naire (SF-36) to assess HRQOL (Ware & Sherbourne, 1992).  The SF-36 items were divided into 
two summary scores: a physical composite score (consisting of four subscales: physical function-
ing, physical role functioning, bodily pain and general health), and a mental composite score 
(consisting of four subscales: vitality, social role functioning, emotional role functioning, and 
mental health).  Scores were transformed to a 0–100 score, with higher scores indicating better 
HRQOL.  The SF-36 showed good reliability with Cronbach alpha values of 0.90 and 0.81 for the 
physical composite score and mental composite score respectively.  The questionnaire also con-
tained the Revised Illness Perception Questionnaire to assess illness perceptions (Moss-Morris et 
al., 2002).  Seven domains were derived from 38 items scored on a 5-point Likert scale ranging 
from 1 (strongly disagree) to 5 (strongly agree): timeline acute/chronic, timeline cyclical, nega-
tive consequences, personal control, treatment control, illness coherence, and emotional response.  
The eighth domain ‘illness identity’ was assessed using a sum-score of 14 items in a yes or no 
format.  Like other studies (e.g. Kim & Evangelista, 2010), illness perception cause was excluded 
from the analysis due to heterogeneous causes of CKD.  Higher scores on domains reflect that 
patients attribute more physical symptoms to their kidney disease (i.e. illness identity), and that 
patients believe to a higher extent their kidney disease is chronic and cyclical in nature, has nega-
tive consequences upon their life, causes emotional distress, can be effectively controlled by 
themselves or their treatment, and that they understand their kidney disease (i.e. illness cohe-
rence).  All domains showed moderate to good reliability with Cronbach alpha values ranging 
from 0.63 to 0.90 (see Meuleman et al., 2015).   
 
Statistical Analysis 
To describe patients’ baseline characteristics, descriptive statistics were computed.  Conti-
nuous variables are presented as mean (standard deviation [SD]) for normally distributed varia-
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bles and as median (interquartile range [IQR]) for skewed variables.  Chi-square tests of associa-
tion and t-tests were conducted to investigate if patients who were included in and excluded from 
analysis differ with regard to baseline characteristics.  
To identify distinct groups of patients that share similar HRQOL trajectories during predia-
lysis care, latent class growth models (LCGM) were used.  LCGM is a model based cluster analy-
sis approach in order to determine whether longitudinal changes in an outcome may be best des-
cribed by a single or multiple distinct trajectories (i.e. classes; see also Nagin & Odgers, 2010).  
Four time points were included in the analysis (i.e. baseline, and follow-up measurements at 6, 12 
and 18 months) to ensure the availability of sufficient HRQOL measurements and fit the models 
adequately (i.e. LCGM needs at least three time point to fit the models).  As suggested by litera-
ture (Jung & Wickrama, 2008; Nylund, Asparouhov, & Muthén, 2007), we determined the opti-
mal number of latent trajectory classes by using a combination of several standard fit indices: 
substantial number of participants in each class (at least 5% of the sample), Bayesian Information 
Criterion (i.e. lower values indicate a better fit), entropy summary measures (i.e. entropy values 
range from zero to one, with values closer to one indicating a better quality of the classification), 
and Vuong-Lo-Mendell-Rubin likelihood test for K-1 vs. K classes (i.e. a p-value less than 0.05 
indicates that the current model has a better fit than the model with 1 class less).  Linear and non-
linear models were evaluated, but in all cases, linear models provided a better fit to the data.  To 
assess the adequacy of the final models, the average posterior probabilities were calculated (i.e. a 
value of at least 0.70 suggests a good probability that participants belong to the assigned class – 
there is homogeneity within the class).  Labels were assigned to each identified class according 
to the corresponding class characteristics: the intercept (i.e. the baseline score, for instance: low, 
medium or high), and the magnitude and direction of the slope (i.e. a statistically significant 
positive or negative change over time, or the absence of a statistically significant change over 
time [i.e. a stable trajectory]) (see results).  A series of univariate logistic regression analyses 
were ran to investigate the association between the separate baseline factors (age, gender, 
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eGFR, BMI, DM, CVD, time since CKD diagnosis, serum albumin, hemoglobin, and illness 
perceptions) and HRQOL class membership (for details see Jung & Wickrama, 2008).  Analy-
ses for illness perceptions were repeated using multinomial logistic regression analysis to adjust 
for age, eGFR, DM and CVD.  For both physical and mental HRQOL models, the reference 
category was the class representing the highest level of HRQOL (see results), and effects are 
expressed as odds ratios (ORs) with 95% confidence intervals (CI).   
Descriptive statistics, Chi-square tests of association and t-tests were conducted using SPSS 
version 24.0.  LCGM and logistic regression analyses were ran in Mplus version 7.3, and all 
models used full-information maximum likelihood estimation to addressing missing data (i.e. 
using all available data under the assumption that data are missing at random) to ensure max-
imum power and avoided bias estimates (Jung & Wickrama, 2008; Muthén & Muthén, 2015).    
P-values of <0.05 were considered statistically significant. 
 
Results 
Of the 502 included patients, 396 patients (78.9%) completed the baseline SF-36 question-
naire (the physical component was completed by 384 patients and the mental component by 394 
patients) and were included in the analysis.  No significant differences in baseline characteristics 
(i.e. illness perceptions, demographic and clinical factors; see Table 1) were observed between 
patients who were included in and excluded from the analysis, with the exception that excluded 
patients attributed less physical symptoms to their kidney disease (illness identity; t= -5.0, p= 
<0.01).  In the included sample, the mean age (SD) was 64.4 (14.0) years and the mean (SD) 
scores for physical and mental HRQOL were 54.6 (22.2) and 67.9 (20.4) respectively. All base-
line characteristics are shown in Table 1.   
During the first 18 months of predialysis care, 20 patients (5.1%) died, 6 patients (1.5%) 
experienced a recovered kidney function, 21 patients (5.3%) received a kidney transplant, 6 
patients (1.5%) were transferred to a non-participating center, 23 patients (5.8%) refused further 
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participation, and 1 patient (0.3%) was censored for other reasons.  Dialysis was initiated in 145 
patients (36.6%; 84 patients [57.9%] started on hemodialysis, and 61 patients [42.1%] on perito-
neal dialysis), and 174 patients (43.9%) still received predialysis care.  The median [IQR] follow-
up time in this sample was 16.1 [7.2-32.0] months).   
 
Distinct Physical HRQOL Trajectory Classes  
A 3-class solution was found to fit the data adequately (Table 2).  The three identified class-
es of physical HRQOL are summarized in Table 3, and Figure 1a depicts the physical HRQOL 
trajectories.  The first class termed “low-stable” contained 34.1% of the patients, and was charac-
terized by low levels of physical HRQOL that remained stable over time.  The second class 
(32.5% of the sample), termed “medium-declining”, was defined by a moderate level of physical 
HRQOL, which significantly worsened with time.  The final class (33.4% of the patients) was a 
“high-increasing” class, and was characterized by a high level of physical HRQOL, which signi-
ficantly increased over time. 
 
Distinct Mental HRQOL Trajectory Classes   
A two-class solution was deemed adequate for mental HRQOL (Table 2).  The two mental 
HRQOL classes are shown in Table 3, and Figure 1b depicts the mental HRQOL trajectories.  
The first class termed “low-stable” contained 38.7% of the patients, and was characterized by low 
levels of mental HRQOL that remained stable over time.  The second class, termed “high-stable” 
(61.3% of the sample), was defined by high levels of mental HRQOL that remained stable over 
time. 
 
Factors Associated with Physical HRQOL Class Membership 
Of the demographic and clinical factors (age, gender, eGFR, BMI, DM, CVD, time since 
CKD diagnosis, serum albumin and hemoglobin) only age and CVD were significantly associated 
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with physical HRQOL class membership: compared to the high-increasing physical HRQOL 
class (class 3), a one-year increase in age was associated with a 4% increase in the odds of being 
in the low-stable physical HRQOL class (class 1; OR=1.04, p<0.01), and the presence of CVD 
was associated with a 2.1 times increase in the odds of being in the low-stable physical HRQOL 
class (class 1; OR=2.1, p<0.01).  Six out of the eight illness perception domains were also signi-
ficantly associated with physical HRQOL class membership while adjusting for age, eGFR and 
comorbidity (see Table 4 for the crude and adjusted odd ratio's).  Increased odds for a low-stable 
physical HRQOL class (class 1) were detected in patients who believed to a lesser extent that 
they can personally control their kidney disease and that they completely understand their con-
dition, compared to the high-increasing physical HRQOL class (class 3). Put another way, a 
single point increase in personal control (higher control) reduced the odds of being in the low-
stable class by 12% (ORadj=0.88, p=<0.01) and a single point increase in coherence (higher 
coherence) was associated with a 15% reduction in the odds of being in the low-stable class 
(ORadj=0.85, p=<0.01).  Furthermore, compared to the high-increasing physical HRQOL class 
(class 3), a one-point increase in illness identity, cyclical timeline, negative consequences and 
emotional response increased the odds of being in the low-stable physical HRQOL class (class 1) 
by 50%, 36%, 14% and 7% respectively.  Similarly, compared to the high-increasing physical 
HRQOL class (class 3), a one-point increase in illness identity was associated with a 21% in-
crease in the odds of being in the medium-declining physical HRQOL class (class 2).  Only 
trends were found for the odds of being in the medium-declining physical HRQOL class (class 2) 
with regard to the illness perceptions cyclical timeline (OR=1.13, p=0.06) and negative conse-
quences (OR=1.14, p=0.05) compared to the high-increasing physical HRQOL class (class 3). 
 
Factors Associated with Mental HRQOL Class Membership 
None of the demographic or clinical factors (age, gender, eGFR, BMI, DM, CVD, time 
since CKD diagnosis, levels of serum albumin and hemoglobin) were significantly associated 
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with mental HRQOL class membership.  Four out of the eight illness perception domains were 
significantly associated with mental HRQOL class membership while adjusting for age, eGFR 
and comorbidity (see Table 5 for the crude and adjusted odd ratio's).  Compared to the high-stable 
mental HRQOL class (class 2), a one-point increase in cyclical timeline, negative consequences 
and emotional response increased the odds of being in the low-stable mental HRQOL class (class 
1) by 22%, 14% and 7% respectively.  Furthermore, increased odds for a low-stable mental 
HRQOL trajectory (class 1) were detected in patients who believed to a lesser extent that they 
completely understand their kidney disease compared to the high-stable mental HRQOL class 
(class 2).  Put another way, a single point increase in coherence (higher coherence) was asso-
ciated with a 16% reduction in the odds of being in the low-stable class (ORadj= 0.84, p=<0.01). 
 
Discussion 
To the best of our knowledge this study is the first to examine distinct trajectories of 
HRQOL in patients receiving predialysis care using LCGM and to investigate which patient cha-
racteristics and illness perceptions at the start of predialysis care are associated with these spe-
cific HRQOL trajectories during predialysis care.   
 This study shows that distinct HRQOL trajectories can be detected during the first 18 
months of predialysis care.  Patients indeed differ to a large extent in their evaluation of HRQOL 
over time, and hence, underlines the importance of investigating heterogeneity of HRQOL in this 
population.  Three physical HRQOL trajectories were observed, all containing approximately 
one-third of our sample: a trajectory in which patients report stable levels of low physical 
HRQOL, a trajectory in which patients report moderate levels of physical HRQOL that worsened 
over time, and a trajectory in which patients report high levels of physical HRQOL that improved 
with time.  Additionally, two mental HRQOL trajectories were identified: one trajectory contain-
ing approximately 60% of our sample in which patients reported stable high levels of mental 
HRQOL, and a second trajectory in which patients reported stable low levels of mental HRQOL.  
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These results highlight that a large proportion of our sample has an unfavorable (i.e. stable low 
or declining) HRQOL trajectory during the first 18 months of predialysis care, which puts 
them at risk for adverse outcomes such as accelerated progression toward ESRD and mortality 
(de Goeij et al., 2014; Tsai et al., 2010).  Furthermore, the findings that HRQOL remained rather 
stable in a large proportion of our sample could, to a certain extent, be considered remarkable as 
the predialysis phase is often considered a dynamic period.  The predialyis phase is characterized 
by an accelerated disease progression, an intensified treatment to treat health complications and 
prepare patients for renal replacement therapy (i.e. dialysis or transplantation), an increase in 
overt physical symptoms and drug-related side effects, and many patients perceive this phase as a 
stressful period during which they experience feelings as helplessness and hopelessness (de Goeij 
et al., 2014; Ekelund & Andersson, 2007; Iles-Smith, 2005; Sijpkens et al., 2008; Tong et al., 
2009).  Therefore, one might expect that most patients report decreasing levels of physical and 
mental HRQOL during predialysis care and this expectation is also in line with previous studies 
that found decreased mean levels of HRQOL during predialysis care (de Goeij et al., 2014).  
However, we did not find decreasing levels of physical and mental HRQOL in the majority of our 
sample and, although speculative, a possible explanation for our findings could be found in the 
phenomenon ‘response shift’.  Response shift refers to a change in individuals’ meaning of 
HRQOL over time due to changes in their internal standard (e.g. a change in idea what poor 
health is), values (e.g. reprioritization the importance of certain life domains) and/or reconcep-
tualization of the concept HRQOL (Sprangers & Schwartz, 1999).  These cognitive changes re-
flect patients’ adaptation to new situations, and could perhaps explain why patients’ evaluation of 
HRQOL did not decline but remained rather stable in a large proportion of our sample despite 
declining health.   Finally, this stability in HRQOL seems particularly applicable to mental 
HRQOL: mental HRQOL remained rather stable in all patients while physical HRQOL remained 
stable in only one-third of our sample.  A possible explanation for this difference could be that 
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predialysis care is relatively more focused on the treatment of physical aspects compared to the 
mental aspects of the disease (Multidisciplinary guidelines predialysis, 2011).      
Antecedent factors associated with different HRQOL trajectories were also examined in 
this study. The results showed that none of the demographic or clinical factors were associated 
with mental HRQOL class membership, however, age and CVD were associated with physical 
HRQOL class membership: increased odds for a low-stable physical HRQOL trajectory were 
detected in older patients and patients diagnosis with CVD.  In addition, six out of the eight 
illness perceptions were associated with HRQOL class membership; increased odds for both a 
low-stable physical and mental HRQOL trajectory were detected in patients who believed to a 
higher extent that their kidney disease has an unpredictable cyclical nature, has negative conse-
quences upon their lives, causes emotional distress, and in patients who believed to a lesser extent 
that they fully understand their kidney disease.  Additionally, increased odds for a low-stable 
physical HRQOL were detected in patients who believed to a lesser extent that they can person-
ally control their disease, and increased odds of a low-stable and medium-declining physical 
HRQOL trajectory was detected in patients who attributed more physical symptoms to their 
kidney disease.  These findings are in line with and builds on previous studies that found lower 
mean levels of HRQOL in patients with CKD associated with an older age (Chin et al., 2008), 
CVD (Chin et al., 2008; Mujais et al., 2009) and stronger negative perceptions of illness, inclu-
ding illness identity, cyclical timeline, negative consequences, personal control, illness coherence 
and emotional response (Covic et al., 2004, 2006; Fowler & Baas, 2006; Griva et al., 2009; 
Timmers et al., 2008).   
An explanation for the relationship between illness perceptions and HRQOL found in 
this study can be derived from the Common Sense Model of self-regulation (Leventhal et al., 
1980, 1984).  This theoretical framework suggests that patients’ perceptions of illness shape 
their cognitive and behavioral adjustment to managing their illness (i.e. coping process and 
illness related behaviors) and consequently contribute to health outcomes.  For our results, 
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this could mean that patients with stronger negative illness perceptions deal with their kidney 
disease in more maladaptive ways (e.g. denial, non-adherence to treatment guidelines, and not 
seeking support), and consequently result in impaired or deteriorating HRQOL.  Until now, 
the evidence for this explanation in patients with CKD is contradictory and limited to only a 
few cross-sectional studies; Knowles, et at. (2014) found (mal)adaptive coping to mediate the 
relationship between illness perceptions and psychological well-being, whereas Kim & Evan-
gelista (2010) did not find adherence to treatment guidelines to mediate the relationship be-
tween illness perceptions and clinical outcomes.  Moreover, a recent meta-analysis also con-
cluded that evidence for coping as a potential mediator in the relationship between illness 
perceptions and psychological health in people with other conditions was inconsistent (Dempster, 
Howell, & McCorry, 2015).  Therefore, additional research is needed to further explore this 
potentially mediating role of coping and health behaviors in the relationship between illness 
perceptions and HRQOL trajectories during predialysis care.   
Taken together, the results of this study suggest that in many patients physical and men-
tal HRQOL remained compromised or became impaired during the first 18 months of predia-
lysis care.  Hence, implementing additional strategies at the start of predialysis care to support 
patients at risk for impaired HRQOL is required.  Our results also suggest that illness percep-
tions are, compared to the demographic and clinical factors, most closely rela ted to HRQOL 
trajectories.  This latter finding is especially important because literature shows that unhelpful 
illness perceptions can be changed by means of psychoeducational interventions, and conse-
quently improve outcomes (Karamanidou, Weinman, & Horne, 2008; Petrie, Cameron, Ellis, 
Buick, & Weinman, 2002).  Based on our results, key aspects of such interventions to opti-
mize HRQOL would be to target unhelpful beliefs about illness identity, cyclical timeline, con-
sequences, personal control, illness coherence and emotional response.  Examples of support 
strategies that could be implemented to target these unhelpful illness perceptions are: education 
(e.g. enhancing knowledge about kidney disease and how they can personally influence disease 
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progression by adopting a healthy lifestyle), challenge misconceptions (e.g. about the unpredicta-
ble cyclical nature of CKD and related symptoms), and develop action plans (e.g. how to deal 
with emotional distress and the negative consequences that the disease has upon their lives, for 
instance by means of reattribution or increasing social support) (Karamanidou et al., 2008; 
Petrie et al., 2002). However, pilot studies are needed to evaluate if illness perception-based 
interventions would indeed improve HRQOL trajectories in patients receiving predialysis 
care.  
The main strength of this study is the longitudinal instead of cross-sectional design that 
provided the opportunity to investigate changes in HRQOL over time.  The PREPARE-2 dataset 
also offers information on a broad range of factors (i.e. HRQOL, illness perceptions, and variety 
of demographic and clinical factors) in a large sample of patients.  A disadvantage of this obser-
vational design is that causal interpretation is still limited.  Furthermore, a selection bias could 
have been introduced as not all eligible patients starting predialysis care have been included in 
this study (i.e. only patients who were asked and willing to participate).  Potentially, unidentified 
confounding could also have led to biased results: i.e. a decreased health status at the start of pre-
dialysis care could have caused both stronger negative illness perceptions and impaired HRQOL 
trajectories.  However, we believe that we adequately adjusted for disease severity (i.e. age, kid-
ney function, and comorbidities), and the results from the crude and adjusted analyses were very 
similar.  Besides this, there is missing data as some patients did not (fully) complete the question-
naire (i.e. the questionnaire was not returned or insufficiently filled out), did not visit the predia-
lysis outpatient clinic every six months or reached a study endpoint.  However, it is unlikely that 
our missing data led to biased results, since little differences in baseline characteristics were ob-
served between patients who were included in and excluded from the analyses.  Moreover, to en-
sure maximum power and avoided bias estimates, missing data was treated using full-information 
maximum likelihood estimation, and there was no evidence that missing data was not random in 
nature.  Finally, additional research is needed to confirm our results, to assess how HRQOL tra-
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jectories develop after 18 months of predialysis care, and to investigate if changes in illness per-
ceptions would also lead to changes in HRQOL trajectories in patients receiving predialysis care.   
Despite these limitations and the need for future research, this study identified various im-
portant markers for unfavorable HRQOL trajectories: an older age and the presence of CVD 
were associated with unfavorable physical HRQOL trajectories, and stronger negative percep-
tions of illness at the start of predialysis care were associated with unfavorable physical and 
mental HRQOL trajectories.  Personalized treatment approaches to optimize HRQOL during 
predialysis care are desired and should take into account illness perceptions.  
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Baseline characteristics (n=396) 
Characteristic  
Demographic  
Age, years, mean ± SD 64.4 (14.0) 
Sex, female, N (%) 135 (34.1) 
Clinical  
Time since CKD diagnosis, median (IQR) years □ 12.0 (9.0-20.0) 
Diabetes mellitus, N (%) 101 (25.5) 
Cardiovascular disease, N (%) 161 (40.7) 
Body mass index (kg/m2), mean ± SD □□ 26.6 ± 5.0 
eGFR (ml/min/1.73m2), mean ± SD □□□ 16.8 ± 6.1 
Serum albumin (g/l), mean  ± SD † 40.9 ± 4.6 
Hemoglobin (g/dl), mean ± SD ‡ 12.3 ± 1.5 
Psychosocial  
Physical HRQOL (range 0-100), mean ± SD *, a 54.6 ± 22.2 
Mental HRQOL (range 0-100), mean ± SD **, a 67.9 ± 20.4 
Illness identity (range 0-14), mean ± SD b 3.1 ± 2.5 
Timeline acute/chronic (range 6-30), mean ± SD b 24.9 ± 4.2 
Cyclical timeline (range 4-20), mean ± SD a 11.3 ± 3.4 
Negative consequences (range 6-30), mean ± SD b 20.6 ± 4.1 
Personal control (range 6-30), mean ± SD b 18.0 ± 4.1 
Treatment control (range 5-25), mean ± SD b 15.2 ± 3.0 
Illness coherence (range 5-25), mean ± SD b 17.4 ± 4.1 
Emotional response (range 6-30), mean ± SD b 16.5 ± 5.3 
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Note.  Continuous variables are presented as mean ± SD for normally distributed variables and as 
median (IQR) for skewed variables.   
Abbreviations: HRQOL, Health-related quality of life; eGFR, estimated glomerular filtration rate; 
SD, standard deviation; IQR, interquartile range. 
Complete data available with the exception of the following variables with data available for: 
□381 (96.2%), □□388 (98.0%), □□□351 (88.6%), †325 (82.1%), ‡349 (88.1%), *384 (97.0%), **394 
(99.5%). 
a Mean scores of the general Dutch population for physical and mental HRQOL are 76.3 and  
  77.9 respectively (these mean physical and mental HRQOL composite scores were calcula- 
  ted based on unstandardized mean scores of the SF-36 subscales described by Aaronson et  
  al., 1998. 
b Higher scores on illness perception domains reflect that patients attribute more physical  
  symptoms to their kidney disease (i.e. illness identity), and that patients believe to a higher  
  extent their kidney disease is chronic and cyclical in nature, has negative consequences  
  upon their life, causes emotional distress, can be effectively controlled by themselves or  
  their treatment, and that they understand their kidney disease (i.e. illness coherence). 




Latent class growth model fit specification for physical and mental HRQOL classes 
Number of classes: 1 2 3 a 4 
Physical HRQOL     
Number of free Parameters 6 9 12 15 
Log likelihood  -4162.26 -3978.54 -3931.15 -3920.26 
Bayesian Information Criterion  8360.54  8011.10  7934.32  7930.55 
Entropy -   0.73   0.67   0.68 
Vuong-Lo-Mendell-Rubin likelihood  
      test for K-1 vs. K classes, p-value - <0.01 <0.01   0.09 
Number of classes: 1 2 b 3 4 
Mental HRQOL     
Number of free Parameters 6 9 12 15 
Log likelihood -4111.98 -3961.41 -3929.53 -3913.31 
Bayesian Information Criterion  8235.96  7976.94  7931.21  7916.79 
Entropy -   0.76   0.67   0.63 
Vuong-Lo-Mendell-Rubin likelihood   
      test for K-1 vs. K classes, p-value - <0.01   0.36   0.03 
 
Abbreviation: HRQOL, Health-related quality of life 
a A three-class solution had the best model fit as determined by the combination of the fit in- 
  dices, and the average posterior probabilities for each trajectory class were higher than 0.70  
  (0.85, 0.77, and 0.90 respectively). 
b A two-class solution had the best model fit as determined by the combination of the fit in- 
  dices, and the average posterior probabilities for each trajectory class were higher than 0.70  
  (0.91 and 0.94, respectively).     
HRQOL TRAJECTORIES DURING PREDIALYSIS CARE                                                      28 
 
 
 Table 3 
Class solutions for physical HRQOL (n=384) and mental HRQOL (n=394) a 
 Trajectory Intercept Slope b     N (%) 
Physical HRQOL     
Class 1 Low-stable 32.45** -0.86 131 (34.1) 
Class 2 Medium-declining 57.10** -3.91** 125 (32.5) 
Class 3 High-increasing 75.28**  1.84* 128 (33.4) 
Mental HRQOL      
Class 1  Low-stable 48.86** -1.41 152 (38.7) 
Class 2 High-stable 80.13** -0.61 242 (61.3) 
 
Abbreviation: HRQOL, Health-related quality of life. 
a The median (IQR) number of HRQOL measurements was 2 (1–3) during the first 18 months  
  of predialysis care. Physical and mental HRQOL scores available at follow-up were: 260  
  (67.7%) and 261 (66.2%) at 6 months, 169 (44.0%) and 168 (42.6%) at 12 months, and 102  
   (26.6%) and 102 (25.9%) at 18 months respectively.   
b Change in HRQOL scores per 6 months during the first 18 months of predialysis care.  
* p < 0.05, **p < 0.01.





Figure 1. Distinct trajectories of HRQOL during the first 18 months of predialysis care:  three 
physical HRQOL trajectories (A; n=384), and two mental HRQOL trajectories (B;  n=394). *p < 








Factors associated with physical HRQOL class membership (n=384) 
 Class 1 a 
Low-stable physical HRQOL 
Class 2 a 
Medium-declining  physical HRQOL 
 Unadjusted 
OR (95% CI) 
Adjusted b 
OR (95% CI) 
Unadjusted 
OR (95% CI) 
Adjusted b 
OR (95% CI) 
Illness identity 1.31 (1.18–1.46)** 1.50 (1.26–1.79)** 1.18 (1.03–1.34)* 1.21 (1.02–1.44)* 
Timeline acute/chronic 0.98 (0.90–1.06) 0.98 (0.90–1.06) 1.03 (0.93–1.15) 1.05 (0.93–1.18) 
Cyclical timeline 1.20 (1.05–1.35)* 1.36 (1.14–1.58)* 1.16 (1.06–1.27)** 1.13 (1.00–1.26) 
Negative consequences 1.08 (1.01–1.16)* 1.14 (1.02–1.25)* 1.18 (1.08–1.23)* 1.14 (1.00–1.28) 
Personal control 0.90 (0.82–0.98)* 0.88 (0.78–0.97)** 0.97 (0.89–1.06) 0.99 (0.90–1.08) 
Treatment control 0.94 (0.77–1.12) 1.11 (0.97–1.24) 0.99 (0.88–1.09) 1.09 (0.96–1.23) 
Illness coherence 0.83 (0.65–1.06) 0.85 (0.74–0.95)** 0.95 (0.81–1.12) 0.95 (0.86–1.03) 
Emotional response 1.02 (0.97–1.08) 1.07 (1.00–1.15)* 1.05 (0.97–1.13) 1.05 (0.96–1.13) 
 
Abbreviations: OR, Odds ratio; CI, confidence interval. 
Note: Higher scores on domains reflect that patients attribute more physical symptoms to their kidney 
disease (i.e. illness identity), and that patients believe to a higher extent their kidney disease is chro-
nic and cyclical in nature, has negative consequences upon their life, causes emotional distress, can 
be effectively controlled by themselves or their treatment, and that they understand their kidney 
disease (i.e. illness coherence). 
a Reference class: high-increasing physical HRQOL (class 3). 
b Adjusted for age, kidney function, and comorbidities. 
*p < 0.05, **p < 0.01. 




Factors associated of mental HRQOL class membership (n=394) 
 Class 1 a 
Low-stable mental HRQOL 
 Unadjusted 
OR (95% CI) 
Adjusted b 
OR (95% CI) 
 
Illness identity 1.24 (1.08–1.42)** 1.06 (0.80–1.26)  
Timeline acute/chronic 0.98 (0.91–1.04) 0.99 (0.92–1.06)  
Cyclical timeline 1.18 (1.09–1.28)** 1.22 (1.11–1.32)**  
Negative consequences 1.10 (1.04–1.18)** 1.14 (1.05–1.23)**  
Personal control 0.94 (0.88–1.00) 0.99 (0.92–1.06)  
Treatment control 1.00 (0.93–1.09) 1.02 (0.93–1.10)  
Illness coherence 0.86 (0.79–0.93)** 0.84 (0.76–0.93)**  
Emotional response 1.06 (0.99–1.12) 1.07 (0.87–0.99) *  
 
Abbreviations: OR, Odds ratio; CI, confidence interval. 
Note:  Higher scores on domains reflect that patients attribute more physical symptoms to their 
kidney disease (i.e. illness identity), and that patients believe to a higher extent their kidney 
disease is chronic and cyclical in nature, has negative consequences upon their life, causes 
emotional distress, can be effectively controlled by themselves or their treatment, and that they 
understand their kidney disease (i.e. illness coherence). 
a Reference class: high-stable mental HRQOL (class 2). 
b Adjusted for age, kidney function, and comorbidities. 
* p < 0.05, **p < 0.01. 
